Results 171 to 180 of about 173,550 (264)

Parenteral CHIKV mRNA Vaccination Reshapes the Gut Microbial, Metabolic, and Immune Landscapes

open access: yesMedComm, Volume 7, Issue 11, November 2026.
This study provides multi‐omics evidence that parenteral mRNA vaccination against CHIKV, even in the absence of viral infection, can profoundly remodel the host intestinal ecosystem—recapitulating key microbial, metabolic, and GI immune features typically associated with active CHIKV infection, characterized by enrichment of Segatella copri, activation
Hongyu Chen   +15 more
wiley   +1 more source

A Model for Estimating the Risk of Gastrointestinal Bleeding for Patients on Oral Anticoagulants and Interacting Medications

open access: yesPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Volume 46, Issue 11, November 2026.
ABSTRACT Introduction Pharmacodynamic drug–drug interactions (DDI) in patients receiving oral anticoagulants (OAC) may increase the risk of gastrointestinal bleeding (GIB). The purpose of this study was to develop and validate a GIB model for patients receiving OACs.
Ainhoa Gomez‐Lumbreras   +5 more
wiley   +1 more source

Gastroschisis‐Like Defect in a Crossbred Bovine Calf: Anatomical, Clinical and Surgical Perspectives

open access: yesVeterinary Medicine and Science, Volume 12, Issue 6, November 2026.
A gastroschisis‐like defect was observed in a one‐day‐old, crossbred bovine calf with evisceration of the pyloric abomasum and small intestine, likely resulting from prenatal rupture of an omphalocele. The calf presented with lethargy, hypothermia and metabolic derangements, along with elevated renal biomarkers.
Mohammad Raguib Munif   +1 more
wiley   +1 more source

FEATURES OF THE ACID-FORMING FUNCTION OF THE STOMACH IN DUODENAL ULCER IN CHILDREN

open access: yes
According to the materials of foreign and domestic statistical studies, duodenal ulcer (duodenal ulcer) in children accounts for 81% of all cases of the disease, gastric ulcer is observed in 13% of cases, and combined localization - in 6% of cases.
Ruzikulov N. E., Ibatova Sh. M.
core  

Retrospective comparison of treatments for equine gastric ulceration syndrome and the influence of inflammatory bowel disease

open access: yesEquine Veterinary Education, Volume 38, Issue 11, Page e882-e891, November 2026.
Summary Background Equine squamous gastric disease (ESGD) and equine glandular gastric disease (EGGD) can be treated with oral omeprazole, combined with sucralfate or an extended‐release intramuscular omeprazole (ERIO). Objectives To evaluate these different treatments for ESGD and EGGD and assess the influence of inflammatory bowel disease (IBD) on ...
L. C. Kranenburg   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy